SYmbicort given as needed in mild asthma (SYGMA study): a retrospective subanalysis of the Russian population.

The subanalysis revealed a delayed prescription of controller (ICS) therapy and overuse of short-acting bronchodilators in the Russian population with mild asthma. These factors can lead to insufficient symptom control and higher risk of severe exacerbation in the Russian population with mild asthma.